Citadel Advisors
FURX

Citadel Advisors’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Citadel Advisors’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,200
Closed -$340K – 8821
2014
Q2 		$340K Sell
3,200
-10,800
-77% -$1.06M ﹤0.01% 4885
2014
Q1 		$1.22M Buy
14,000
+10,000
+250% +$772K ﹤0.01% 3191
2013
Q4 		$168K Buy
4,000
+1,500
+60% +$61.7K ﹤0.01% 5199
2013
Q3 		$110K Buy
2,500
+1,300
+108% +$53.8K ﹤0.01% 5292
2013
Q2 		$41K Buy
+1,200
New +$42.1K ﹤0.01% 5769

Citadel Advisors's FURX Position: Q3 2014 in Review

Citadel Advisors sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 1,597 shares — an estimated $170K sold.

Citadel Advisors first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $897K in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Citadel Advisors reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Citadel Advisors sold 1,597 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $170K.
  • Citadel Advisors first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Citadel Advisors's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $897K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Citadel Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.